Chemotherapy plus immunotherapy in the simultaneous treatment of lung cancer may achieve better results, specifically related to the patient’s age, condition and drug tolerance situation.
Lung cancer is a malignant tumor originated from the mucosa of trachea and bronchus, which is mainly treated by surgery, and chemotherapy plus immunotherapy can be adopted for patients who are intolerant to surgery and have advanced pathological stage, which is also the main treatment mode at present.
If the patients are younger, without underlying diseases, with high sensitivity and good tolerance to chemotherapy and immunotherapy drugs, the treatment effect may be better, which can improve the survival rate of the patients and control the development of the disease. If the patients are of high age, have many basic diseases and poor tolerance to drugs, the treatment effect will be reduced accordingly.
Lung cancer patients should achieve early detection, early diagnosis and early treatment to improve patients’ survival. It is important to pay attention to regular review in daily life to monitor the changes of the disease and consult the doctor in time when any abnormality occurs.